US Patent Issued to DIQI PHARMACEUTICALS on Jan. 27 for "Oral sustained-release composition for insoluble drug, and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,320, issued on Jan. 27, was assigned to DIQI PHARMACEUTICALS Co. LTD. (Guangzhou, China).

"Oral sustained-release composition for insoluble drug, and preparation method thereof" was invented by Feng Liu (Guangzhou, China), Xiaofeng Tan (Guangzhou, China), Wenwei Liang (Guangzhou, China), Weijie Zhou (Guangzhou, China) and Junlong Huang (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an oral sustained-release composition for an insoluble drug, which is especially suitable for a low-dose insoluble drug, the oral sustained-release composition comprises a sustained-release granule part and a gel skeleton part, the sustained...